Report Highlights
The global bio decontamination market should reach $166.9 million by 2022 and more than $232 million by 2027, with a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2022-2027.
Report Includes
- 21 data tables and 25 additional tables
- An in-depth overview of the global market for bio decontamination equipment, consumables, and services
- Analyses of the global market trends, with historic market revenue for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the current and future market potential for bio decontamination equipment, consumables, and services, along with a detailed analysis of the drivers, restraints, and opportunities in the prevailing market
- Estimation of the actual market size and revenue forecast for bio decontamination market in USD million values, and the corresponding market share analysis based on product type, agent, type of decontamination, end-user vertical, and region
- Identification of the key market drivers and constraints that will shape the market for biological decontamination products as the basis for projecting demand over the next five years (2022-2027)
- Country specific data and analysis for the U.S., Canada, Mexico, U.K., Germany, Italy, Japan, China, and India etc.
- Holistic review of the COVID-19 pandemic impact on the global bio decontamination market
- Emphasis on the major growth strategies adopted by leading players of global bio decontamination market, their product launches, key mergers and acquisitions, and competitive benchmarking
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Company profiles of major players within the industry, including Ecolab, Fedegari Autoclavi S.p.A., Steris, Tomi Environmental Solutions and JCE Biotechnology
Report Scope
This report highlights the current and future market potential of bio decontamination along with a detailed analysis of the drivers, restraints and opportunities in the market. The report also covers market projections to 2027 and market rankings for leading companies. It also covers the competitive environment and regulatory scenario. The report details the market share of bio decontamination, based on product, agent, type and end user.
The market by product is segmented into equipment, consumables and services. The market by agent is segmented into hydrogen peroxide, chlorine dioxide, peracetic acid and nitrogen dioxide. The market by type is segmented into room and chamber bio decontamination based on type. The market by end user is segmented into Pharmaceutical and medical device manufacturers, life sciences and biotechnology research organizations, and hospitals and healthcare facilities. The end users such as food industry is not part of the study.
The report includes the company profiles of the key players with information about their business segments, financials, product portfolios and recent developments. The report also analyzes the impact of the COVID-19 pandemic on this market.
By region, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (Row). The North American region includes the U.S., Canada and Mexico. In this report, Europe includes Germany, the U.K., Italy and the Rest of Europe. Similarly, Asia-Pacific is said to include China, India, Japan and the Rest of Asia-Pacific. For market estimates, data has been provided for 2019 as the historic year, 2021 as the base year, and forecasts for 2027.
Report Synopsis
Report Metrics | Details | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2021 | ||||||||||||||
Forecast period considered | 2022-2027 | ||||||||||||||
Base year market size | $157.5 million | ||||||||||||||
Market size forecast | $232.0 million | ||||||||||||||
Growth rate | CAGR of 6.8% from 2022 to 2027 | ||||||||||||||
Units considered | $ Millions | ||||||||||||||
Segments covered | Product, Agent, Type, End User, Region | ||||||||||||||
Regions covered | North America, Europe, Asia Pacific, Rest of the World (RoW)-Middle East and Africa, and South America | ||||||||||||||
Countries covered | U.S., Mexico, Canada, U.K., Germany, Italy, Rest of Europe, China, India, Japan, Rest of APAC | ||||||||||||||
Key Market Drivers |
|
||||||||||||||
Companies studied |
|
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Global Markets for Sterilization Technologies
The global sterilization technologies market reached $8 billion in 2022 and should reach $12.3 billion by 2027, with a compound annual growth rate (CAGR) of 8.8% during the forecast period of 2022-2027.
Sterile Filtration Market for Lifescience
The global sterile filtration market should reach $5.3 billion by 2027 from $3.0 billion in 2022 at a compound annual growth rate (CAGR) of 12.0% for the forecast period of 2022 to 2027.
Healthcare-Acquired Infections: Devices, Pharmaceuticals, and Environmental Products
The global market HCAI Control should grow from $24.0 billion in 2021 to $36.2 billion by 2026, at compound annual growth rate (CAGR) of 8.6% for the period of 2021-2026.
Recent Reports
RNA Sequencing: Technologies and Global Markets
The global market for RNA sequencing is expected to grow from $4.3 billion in 2024 and is projected to reach $10.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.1% during the forecast period of 2024 to 2029.
Antibody Drugs: Technologies and Global Markets
The global market for antibody drugs is expected to grow from $242.6 billion in 2024 and is projected to reach $412.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.2% during the forecast period of 2024 to 2029.
European Life Science Tools and Reagents Market
The European market for life science tools and reagents and COVID-19 diagnostics products was valued at $14.7 billion in 2023. The market is expected to grow from $13.0 billion in 2024 to $15.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 3.4% from 2024 through 2029.
Global Multiomics Market
The global market for multiomics is expected to grow from $2.7 billion in 2024 and is projected to reach $5.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.5% during the forecast period of 2024 to 2029.
Drug Discovery Technologies
The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.
Top Trending Reports
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
Drug Discovery Technologies
The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 and is projected to reach $197.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.0% during the forecast period of 2024 to 2029.
Artificial Intelligence (AI) in Life Sciences Market
The global market for artificial intelligence (AI) in life sciences products was valued at $8.0 billion in 2023. The market is estimated to grow from $9.8 billion in 2024 to $33.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.9% from 2024 to 2029.
Synthetic Biology: Global Markets
The global market for synthetic biology products was valued at $15.4 billion in 2023. The market is projected to grow from $19.3 billion in 2024 to $61.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 26.1% from 2024 through 2029.
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More